Universitätsklinikum Tübingen

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer (2018) Woeckel A, Festl J, Stueber T, Brust K, Krockenberger M, Heuschmann PU, Jiru-Hillmann S, et al. Journal article Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer (2018) Woeckel A, Festl J, Stueber T, Brust K, Stangl S, Heuschmann PU, Albert US, et al. Journal article Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial (2018) Kuhlen M, Bader P, Sauer M, Albert MH, Gruhn B, Gungor T, Kropshofer G, et al. Journal article Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL (2018) Boegemann M, Bedke J, Schostak M, Welslau M, Hering-Schubert C, Wolf T, Schleicher J, et al. Conference contribution Economic evaluation of cognitive behavioral therapy and Internet-based guided self-help for binge-eating disorder (2018) Koenig HH, Bleibler F, Friederich HC, Herpertz S, Lam T, Mayr A, Schmidt F, et al. Journal article Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study (2018) Kremer A, Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, et al. Conference contribution Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV (2018) Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, et al. Journal article The Generation of CAR-transfected NKT Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Marz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin (2018) Schaeffeler E, Büttner F, Reustle A, Klumpp V, Winter S, Rausch S, Fisel P, et al. Journal article Influence of previous Radiotherapy on the Success of an immune-oncologic Therapy in metastatic Melanoma - a retrospective multicenter Study of ADO (2018) Knispel S, Zimmer L, Gutzmer R, Heinzerling L, Weishaupt C, Pfoehler C, Gesierich A, et al. Conference contribution